SBIR Phase II: New ingredients technology to enhance the safety, quality, and value of active substances for pharmaceuticals, food, and personal care

SBIR 第二阶段:新成分技术,提高药品、食品和个人护理活性物质的安全性、质量和价值

基本信息

  • 批准号:
    1556121
  • 负责人:
  • 金额:
    $ 74.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be accomplished through a proprietary technology with its extraordinary capability to enable a large number of high-value, hard-to-formulate active ingredients for pharmaceutical, food, and personal care products. In the pharmaceutical and personal care industries, this technology is able to solubilize and enable poorly water-soluble drug substances to achieve enhanced therapeutic effect, improved safety profile, and reduced cost. In addition, it may strongly support the long-term activities of drug discovery and development through activating potentially efficacious, but hard-to-handle chemical entities. By supporting new drugs development and reducing manufacturing cost, this technology will benefit the public health and meanwhile create commercial values to the industry. In the food and supplement industries, this technology may enable the industry to replace non-healthy or even hazardous additives, such as artificial colors and preservatives, with natural and healthy alternatives, thus greatly contribute to long-term food safety and security as well as public health. To achieve commercialization success, a solid portfolio of intellectual properties has been established. Seasoned business leaders will work with renowned scientists to incorporate cutting-edge technologies into drug, food & nutrition, and personal care products. The proposed project will substantially support the development of this new technology. The core problem/opportunity this technology targets is a large number of high-value whereas poorly water-soluble active ingredients that have been challenging the drug and food industry for a long time. For example, around 80% of drug candidates identified by modern drug discovery technologies are poorly water-soluble. For food, a large number of vitamins, nutrients, antioxidants, and natural colors are poorly water-soluble. Overall, poorly water-soluble compounds constitute an enormous formulation challenge. To address this need, this team has created a platform technology that is highly effective and non-specific. The goal of this project is to further develop the technology, scale up the synthesis of a core material, obtain the data on its safety profile, and advance the commercialization activities by providing prototypes to potential customers. This project will be conducted through close collaborations among the start-up company, a major university, and a number of major pharmaceutical, ingredients, food, and personal care companies. The deliverables of this project include the specifications of core material, initial safety evaluations, and prototypes provided to customers. This project will support the start-up company to form a solid foundation for commercialization and long-term growth.
这项小企业创新研究(SBIR)二期项目的更广泛影响/商业潜力将通过一项专有技术来实现,该技术具有非凡的能力,可以为制药、食品和个人护理产品提供大量高价值、难以配制的活性成分。在制药和个人护理行业,该技术能够溶解和使水溶性差的药物物质达到增强治疗效果、提高安全性和降低成本的目的。此外,它可以通过激活潜在有效但难以处理的化学实体,有力地支持药物发现和开发的长期活动。通过支持新药开发和降低制造成本,这项技术将有利于公众健康,同时为行业创造商业价值。在食品和补充剂行业,这项技术可以使该行业用天然和健康的替代品取代非健康甚至有害的添加剂,如人工色素和防腐剂,从而大大有助于长期的食品安全和保障以及公众健康。为了实现商业化的成功,已经建立了坚实的知识产权组合。经验丰富的商业领袖将与知名科学家合作,将尖端技术融入到药品、食品和营养以及个人护理产品中。拟议的项目将大力支持这项新技术的发展。该技术针对的核心问题/机遇是大量高价值但水溶性差的活性成分,这些成分长期以来一直是药品和食品工业的挑战。例如,现代药物发现技术鉴定出的候选药物中,约80%水溶性较差。对于食物来说,大量的维生素、营养物质、抗氧化剂和天然色素的水溶性都很差。总的来说,水溶性差的化合物构成了一个巨大的配方挑战。为了满足这一需求,该团队创建了一种高效且非特定的平台技术。该项目的目标是进一步发展该技术,扩大核心材料的合成规模,获得其安全性数据,并通过向潜在客户提供原型来推进商业化活动。该项目将通过初创公司、一所主要大学以及一些主要的制药、配料、食品和个人护理公司之间的密切合作来进行。该项目的交付成果包括核心材料的规格、初步安全评估和向客户提供的原型。该项目将支持创业公司为商业化和长期增长奠定坚实的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Henry Havel其他文献

Nanomedicines: From Bench to Bedside and Beyond
  • DOI:
    10.1208/s12248-016-9961-7
  • 发表时间:
    2016-08-01
  • 期刊:
  • 影响因子:
    3.700
  • 作者:
    Henry Havel;Gregory Finch;Pamela Strode;Marc Wolfgang;Stephen Zale;Iulian Bobe;Hagop Youssoufian;Matthew Peterson;Maggie Liu
  • 通讯作者:
    Maggie Liu

Henry Havel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 批准年份:
    2019
  • 资助金额:
    3350 万元
  • 项目类别:
    国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 批准年份:
    2018
  • 资助金额:
    12.0 万元
  • 项目类别:
    青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
  • 批准号:
    61675216
  • 批准年份:
    2016
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
基于Phase-type分布的多状态系统可靠性模型研究
  • 批准号:
    71501183
  • 批准年份:
    2015
  • 资助金额:
    17.4 万元
  • 项目类别:
    青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
  • 批准号:
    51201142
  • 批准年份:
    2012
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
  • 批准号:
    11101428
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
  • 批准号:
    19374069
  • 批准年份:
    1993
  • 资助金额:
    6.4 万元
  • 项目类别:
    面上项目

相似海外基金

SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
  • 批准号:
    2321862
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
  • 批准号:
    2335175
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
  • 批准号:
    2335265
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
  • 批准号:
    2335464
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
  • 批准号:
    2335504
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Sodium-Based Solid-State Batteries for Stationary Energy Storage
SBIR第二阶段:用于固定储能的钠基固态电池
  • 批准号:
    2331724
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
  • 批准号:
    2233106
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
  • 批准号:
    2226026
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: High-Performance Batteries to Decarbonize Heavy Duty Construction Equipment
SBIR 第二阶段:高性能电池使重型建筑设备脱碳
  • 批准号:
    2335320
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Technology for Stimulating the Herd Instinct of Livestock to Reduce Environmental Impact
SBIR第二阶段:刺激牲畜的群体本能以减少环境影响的技术
  • 批准号:
    2335554
  • 财政年份:
    2024
  • 资助金额:
    $ 74.98万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了